The merged entity, Opko, has an initial focus on drugs for ophthalmic disorders. Acuity Pharmaceuticals, Froptix, and eXegenics will merge to form Opko. The new biopharmaceutical company plans to list ...
ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Acuity Brands, Inc.’s (NYSE: AYI) corporate name is changing from Acuity Brands, Inc. to Acuity Inc. effective March 26, 2025. Acuity will continue to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback